Skip to main content
OpenTrials

Clinical trial condition

Neoplasms by Site

Explore clinical trials studying Neoplasms by Site. Study availability and eligibility vary by location and protocol.

50,540 public trials 10,738 recruiting studies
Refine in advanced search Browse all conditions

Neoplasms by Site trial results

Recruiting

Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to Radiation Therapy Compared to the Usual Chemotherapy Treatment During Radiation Therapy for Bladder Cancer, PARRC Trial

NCT06770582

Conditions
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, +11 more
Locations
  • Highlands Oncology Group - Fayetteville Fayetteville, Arkansas, United States
  • Highlands Oncology Group - Rogers Rogers, Arkansas, United States
  • Highlands Oncology Group Springdale, Arkansas, United States
  • AIS Cancer Center at San Joaquin Community Hospital Bakersfield, California, United States
View all 138 locations
View Trial Details
Recruiting

A Study Evaluating the Safety, Pharmacokinetics, and Activity of RO7656594 In Participants With Advanced or Metastatic Prostate Cancer

NCT05800665

Conditions
Advanced Prostate Cancer, Genital Diseases, Genital Diseases, Male, +9 more
Locations
  • HonorHealth Scottsdale, Arizona, United States
  • Yale Cancer Center New Haven, Connecticut, United States
  • Sarah Cannon Research Institute @ Florida Cancer Orlando, Florida, United States
  • University of Illinois Hospital & Health Sciences System Chicago, Illinois, United States
View all 26 locations
View Trial Details
Recruiting

A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer

NCT06793215

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
Locations
  • Alaska Oncology and Hematology Anchorage, Alaska, United States
  • City of Hope - Phoenix Goodyear, Arizona, United States
  • Marin Cancer Care Inc Greenbrae, California, United States
  • Hoag Memorial Hospital Newport Beach, California, United States
View all 280 locations
View Trial Details
Recruiting

A Study of LOXO-783 in Patients With Breast Cancer/Other Solid Tumors

NCT05307705

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +4 more
Locations
  • Mayo Clinic of Scottsdale Scottsdale, Arizona, United States
  • UCLA Medical Center Los Angeles, California, United States
  • UCSF Medical Center at Mission Bay San Francisco, California, United States
  • Stanford University Hospital Stanford, California, United States
View all 50 locations
View Trial Details
Recruiting

A Study to Assess Adverse Events and How Intravenously (IV) Infused Telisotuzumab Vedotin (ABBV-399) Moves Through the Body as a Monotherapy in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)

NCT06568939

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Ironwood Cancer and Research Center /ID# 276370 Chandler, Arizona, United States
  • University of Arkansas for Medical Sciences /ID# 272923 Little Rock, Arkansas, United States
  • Valkyrie Clinical Trials /ID# 271322 Los Angeles, California, United States
  • Yale New Haven Hospital /ID# 271584 New Haven, Connecticut, United States
View all 80 locations
View Trial Details
Recruiting

A Study of LY4050784 in Participants With Advanced or Metastatic Solid Tumors

NCT06561685

Conditions
Adenocarcinoma, Advanced Solid Tumor, Bronchial Neoplasms, +21 more
Locations
  • UCLA Santa Monica, California, United States
  • University of Colorado Health Hospital Aurora, Colorado, United States
  • Sarah Cannon Research Institute at HealthOne Denver, Colorado, United States
  • Florida Cancer Specialists ORLANDO/DDU Lake Mary, Florida, United States
View all 33 locations
View Trial Details
Recruiting

A Study to Evaluate the Efficacy of Pumitamig Versus Pembrolizumab in Participants With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%. (ROSETTA Lung-202)

NCT07361510

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Southern Cancer Center Pc Daphne, Alabama, United States
  • Mohtaseb Cancer Center & Blood Disorders Bullhead City, Arizona, United States
  • Palo Verde Hematology Oncology Glendale, Arizona, United States
  • Orange Coast Memorial Medical Center Fountain Valley, California, United States
View all 279 locations
View Trial Details

Related conditions